Target Price | $88.53 |
Price | $72.48 |
Potential |
22.15%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target Insmed Incorporated 2025 .
The average Insmed Incorporated target price is $88.53.
This is
22.15%
register free of charge
$103.00
42.11%
register free of charge
$75.00
3.48%
register free of charge
|
|
A rating was issued by 17 analysts: 17 Analysts recommend Insmed Incorporated to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Insmed Incorporated stock has an average upside potential 2025 of
22.15%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 305.21 | 357.34 |
24.39% | 17.08% | |
EBITDA Margin | -219.64% | -216.68% |
18.74% | 1.35% | |
Net Margin | -291.61% | -243.41% |
9.79% | 16.53% |
14 Analysts have issued a sales forecast Insmed Incorporated 2024 . The average Insmed Incorporated sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Insmed Incorporated EBITDA forecast 2024. The average Insmed Incorporated EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 Insmed Incorporated Analysts have issued a net profit forecast 2024. The average Insmed Incorporated net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -5.34 | -5.22 |
36.57% | 2.25% | |
P/E | negative | |
EV/Sales | 35.23 |
16 Analysts have issued a Insmed Incorporated forecast for earnings per share. The average Insmed Incorporated <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Insmed Incorporated stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Insmed Incorporated...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.